• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH DADE ACTIN FS ACTIVATED PTT REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH DADE ACTIN FS ACTIVATED PTT REAGENT Back to Search Results
Model Number DADE ACTIN FS ACTIVATED PTT REAGENT
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/16/2018
Event Type  malfunction  
Manufacturer Narrative
The customer contacted siemens customer care center and reported that a discordant, falsely elevated activated partial thromboplastin time (aptt) result was obtained using the dade actin fs activated ptt reagent from lot 538524.The customer reported that they observed flocculation in the reagent vials and that quality controls (qcs) were within expected ranges on the day of the event.The customer provided an affected reagent vial and an unaffected reagent vial for further investigation.Siemens ran a study using internal dade actin fs activated ptt reagent vials from lot 538524 and the reagent vials provided by the customer.Siemens determined that qcs recovered within table of assigned values (tavs) ranges using the customer's vial without flocculation and outside of tavs ranges using the customer's vials with flocculation.Five normal patient samples and fresh frozen plasma were also tested for aptt using these vials; the results obtained using unaffected reagent vial provided by the customer and the internal reagent vials recovered as expected.The results obtained using the affected reagent vial recovered higher than expected.Siemens investigated the log files and determined that the affected reagent vial was changed directly before the discordant result was obtained.The customer reported that they switched to another dade actin fs activated ptt reagent lot 538546.The cause of the event is unknown.No further evaluation of this device is required.The rilibäk compliant dade actin fs activated ptt reagent with catalog number 10284498 described is not marketed in the united states (us) and the pma/510(k) number is for the us specific dade actin fs activated ptt reagents.The dade actin fs activated ptt reagent lots marketed in the us have catalog numbers 10445712 and 10445710.
 
Event Description
A discordant, falsely elevated activated partial thromboplastin time (aptt) result was obtained on a patient sample using the dade actin fs activated ptt reagent from lot 538524 on the sysmex cs-2500 system.The discordant result was reported to the physician(s), who questioned the result.The same sample was rerun twice, using another vial of dade actin fs activated ptt reagent from lot 538524, and expected results were obtained.The result obtained using the alternate reagent vial was reported, as the correct result, to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the discordant, falsely elevated aptt result.
 
Manufacturer Narrative
Additional information (16-may-2018): siemens further investigated the cause of the event and determined that the customer did not run quality controls with the affected reagent vial.As per the dade actin fs activated ptt reagent's instruction for use (ifu), "two controls (one in the normal range and one in the pathological/therapeutical range) must be measured at the start of the test run, after each change of reagent vial, and at least once during an 8-hour shift.If the control values are outside of the confidence interval, the controls, reagents and instrument must be checked." siemens determined that the quality control recovery, using the affected vial, would have potentially recovered out of expected ranges, invalidating the discordant results obtained.Additionally, siemens inspected 21 reagent vials that have been stored at our manufacturing site and did not observe flocculation in any of these vials.Siemens concluded that the cause of the event was potentially contributed to a storage issue or was isolated to a single shipment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DADE ACTIN FS ACTIVATED PTT REAGENT
Type of Device
DADE ACTIN FS ACTIVATED PTT REAGENT
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
emil-von-behring- str. 76
marburg, D-350 41
GM  D-35041
MDR Report Key7508851
MDR Text Key108161305
Report Number9610806-2018-00047
Device Sequence Number1
Product Code GGW
Combination Product (y/n)N
PMA/PMN Number
K811589
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 06/08/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/11/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/30/2019
Device Model NumberDADE ACTIN FS ACTIVATED PTT REAGENT
Device Catalogue Number10284498 (SEE SECTION H10)
Device Lot Number538524
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received05/16/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-